CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Tumor-infiltrating CD8+ T cells are strongly associated with patient survival in a wide variety of human cancers. Less is known about tumor-infiltrating CD20+ B cells, which often colocalize with T cells, sometimes forming organized lymphoid structures. In autoimmunity and organ transplantation, T cells and B cells collaborate to generate potent, unrelenting immune responses that can result in extensive tissue damage and organ rejection. In these settings, B cells enhance T cell responses by producing Abs, stimulatory cytokines, and chemokines, serving as local APCs, and organizing the formation of tertiary lymphoid structures that sustain long-term immunity. Thus, B cells are an important component of immunological circuits associated with persistent, rampant tissue destruction. Engagement of tumor-reactive B cells may be an important condition for generating potent, long-term T cell responses against cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Reciprocal regulation of polarized cytokine production by effector B and T cells
Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., Johnson, L. L., Swain, S. L., & Lund, F. E. (2000) · Nature Immunology · doi:10.1038/82717 · Cited by 839
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Hengstler, J. G., Kölbl, H., & Gehrmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 836
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776
Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling
Sarwal, M., Chua, M.-S., Kambham, N., Hsieh, S.-C., Satterwhite, T., Masek, M., & Salvatierra, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035588 · Cited by 701
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Cytokine-producing B lymphocytes-key regulators of immunity
Lund, F. E. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.003 · Cited by 556
Cited by
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.49 · Cited by 2,206
Pitt, J. M., Marabelle, A., Eggermont, A., Soria, J.-C., Kroemer, G., & Zitvogel, L. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw168 · Cited by 1,338
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Gu-Trantien, C., Loi, S., Garaud, S., Equeter, C., Libin, M., de Wind, A., Ravoet, M., Le Buanec, H., Sibille, C., Manfouo-Foutsop, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67428 · Cited by 1,070
Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Vaccines for established cancer: overcoming the challenges posed by immune evasion
van der Burg, S. H., Arens, R., Ossendorp, F., van Hall, T., & Melief, C. J. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.16 · Cited by 709
B cells, plasma cells and antibody repertoires in the tumour microenvironment
Sharonov, G. V., Serebrovskaya, E. O., Yuzhakova, D. V., Britanova, O. V., & Chudakov, D. M. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0257-x · Cited by 627
Lu, K., He, C., Guo, N., Chan, C., Ni, K., Lan, G., Tang, H., Pelizzari, C., Fu, Y.-X., Spiotto, M. T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0203-4 · Cited by 596
Cancer stemness, intratumoral heterogeneity, and immune response across cancers
Miranda, A., Hamilton, P. T., Zhang, A. W., Pattnaik, S., Becht, E., Mezheyeuski, A., Bruun, J., Micke, P., de Reynies, A., & Nelson, B. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818210116 · Cited by 576
Self-citationNielsen, J. S., Sahota, R. A., Milne, K., Kost, S. E., Nesslinger, N. J., Watson, P. H., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0234 · Cited by 553
Self-citationRomero-Garcia, S., Moreno-Altamirano, M. M. B., Prado-Garcia, H., & Sánchez-García, F. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00052 · Cited by 506
Leukocyte composition of human breast cancer
Ruffell, B., Au, A., Rugo, H. S., Esserman, L. J., Hwang, E. S., & Coussens, L. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104303108 · Cited by 479
Hollern, D. P., Xu, N., Thennavan, A., Glodowski, C., Garcia-Recio, S., Mott, K. R., He, X., Garay, J. P., Carey-Ewend, K., Marron, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.028 · Cited by 478
Garnelo, M., Tan, A., Her, Z., Yeong, J., Lim, C. J., Chen, J., Lim, K. H., Weber, A., Chow, P., Chung, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310814 · Cited by 461
B lymphocytes and cancer: a love-hate relationship
Yuen, G. J., Demissie, E., & Pillai, S. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.10.010 · Cited by 433
“By contrast, mouse models of cancer, which are usually accompanied by rapid responses reminiscent of viral infections, might not provide an accurate representation of the chronic anticancer immune responses seen in humans [11].”
InfluentialTargeting B cell receptor signalling in cancer: preclinical and clinical advances
Burger, J. A., & Wiestner, A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.121 · Cited by 431
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
Patil, N. S., Nabet, B. Y., Müller, S., Koeppen, H., Zou, W., Giltnane, J., Au-Yeung, A., Srivats, S., Cheng, J. H., Takahashi, C., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.02.002 · Cited by 408
PD-1 Blockade Expands Intratumoral Memory T Cells
Ribas, A., Shin, D. S., Zaretsky, J., Frederiksen, J., Cornish, A., Avramis, E., Seja, E., Kivork, C., Siebert, J., Kaplan-Lefko, P., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0210 · Cited by 405
“The significant enrichment of B cells in the tumormicroenvironment may have a role in local antigen presentation (35).”
BackgroundDi Caro, G., Bergomas, F., Grizzi, F., Doni, A., Bianchi, P., Malesci, A., Laghi, L., Allavena, P., Mantovani, A., & Marchesi, F. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2590 · Cited by 386
Hiraoka, N., Ino, Y., Yamazaki-Itoh, R., Kanai, Y., Kosuge, T., & Shimada, K. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.145 · Cited by 367
Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells
Lindner, S., Dahlke, K., Sontheimer, K., Hagn, M., Kaltenmeier, C., Barth, T. F. E., Beyer, T., Reister, F., Fabricius, D., Lotfi, R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3450 · Cited by 363
Ruffin, A. T., Cillo, A. R., Tabib, T., Liu, A., Onkar, S., Kunning, S. R., Lampenfeld, C., Atiya, H. I., Abecassis, I., Kürten, C. H. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23355-x · Cited by 361
Xiao, X., Lao, X.-M., Chen, M.-M., Liu, R.-X., Wei, Y., Ouyang, F.-Z., Chen, D.-P., Zhao, X.-Y., Zhao, Q., Li, X.-F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1408 · Cited by 352
The Emerging Role of B Cells in Tumor Immunity
Tsou, P., Katayama, H., Ostrin, E. J., & Hanash, S. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0431 · Cited by 345
Marra, A., Trapani, D., Viale, G., Criscitiello, C., & Curigliano, G. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00197-2 · Cited by 317
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment
Ruffin, A. T., Li, H., Vujanovic, L., Zandberg, D. P., Ferris, R. L., & Bruno, T. C. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00531-9 · Cited by 305
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Affara, N. I., Ruffell, B., Medler, T. R., Gunderson, A. J., Johansson, M., Bornstein, S., Bergsland, E., Steinhoff, M., Li, Y., Gong, Q., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.026 · Cited by 304
Tumor infiltrating immune cells in gliomas and meningiomas
Domingues, P., González-Tablas, M., Otero, Á., Pascual, D., Miranda, D., Ruiz, L., Sousa, P., Ciudad, J., Gonçalves, J. M., Lopes, M. C., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.019 · Cited by 302
Bruno, T. C., Ebner, P. J., Moore, B. L., Squalls, O. G., Waugh, K. A., Eruslanov, E. B., Singhal, S., Mitchell, J. D., Franklin, W. A., Merrick, D. T., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0075 · Cited by 301
Shaashua, L., Shabat-Simon, M., Haldar, R., Matzner, P., Zmora, O., Shabtai, M., Sharon, E., Allweis, T., Barshack, I., Hayman, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0152 · Cited by 276
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
Castino, G. F., Cortese, N., Capretti, G., Serio, S., Di Caro, G., Mineri, R., Magrini, E., Grizzi, F., Cappello, P., Novelli, F., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1085147 · Cited by 246
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
Casazza, A., Di Conza, G., Wenes, M., Finisguerra, V, Deschoemaeker, S., & Mazzone, M. (2014) · Oncogene · doi:10.1038/onc.2013.121 · Cited by 243
Shi, J.-Y., Gao, Q., Wang, Z.-C., Zhou, J., Wang, X.-Y., Min, Z.-H., Shi, Y.-H., Shi, G.-M., Ding, Z.-B., Ke, A.-W., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3497 · Cited by 240
Emerging immunotherapy for HCC: A guide for hepatologists
Foerster, F., Gairing, S. J., Ilyas, S. I., & Galle, P. R. (2022) · Hepatology · doi:10.1002/hep.32447 · Cited by 240
Montfort, A., Pearce, O., Maniati, E., Vincent, B. G., Bixby, L., Böhm, S., Dowe, T., Wilkes, E. H., Chakravarty, P., Thompson, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0081 · Cited by 231
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
Marshall, E. A., Ng, K. W., Kung, S. H. Y., Conway, E. M., Martinez, V. D., Halvorsen, E. C., Rowbotham, D. A., Vucic, E. A., Plumb, A. W., Becker-Santos, D. D., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0551-1 · Cited by 231
Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity
Engelhard, V. H., Rodriguez, A. B., Mauldin, I. S., Woods, A. N., Peske, J. D., & Slingluff, C. L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701269 · Cited by 228
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Issa-Nummer, Y., Darb-Esfahani, S., Loibl, S., Kunz, G., Nekljudova, V., Schrader, I., Sinn, B. V., Ulmer, H.-U., Kronenwett, R., Just, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079775 · Cited by 224
Burugu, S., Asleh-Aburaya, K., & Nielsen, T. O. (2017) · Breast Cancer · doi:10.1007/s12282-016-0698-z · Cited by 222
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
Daniel, S. K., Sullivan, K. M., Labadie, K. P., & Pillarisetty, V. G. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0226-9 · Cited by 207
Applications of Immunogenomics to Cancer
Liu, X. S., & Mardis, E. R. (2017) · Cell · doi:10.1016/j.cell.2017.01.014 · Cited by 205
Prognostic impact of B-cell density in cutaneous melanoma
Ladányi, A., Kiss, J., Mohos, A., Somlai, B., Liszkay, G., Gilde, K., Fejős, Z., Gaudi, I., Dobos, J., & Tímár, J. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1071-x · Cited by 199
Truxova, I., Kasikova, L., Hensler, M., Skapa, P., Laco, J., Pecen, L., Belicova, L., Praznovec, I., Halaska, M. J., Brtnicky, T., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0446-3 · Cited by 191
Landscape of B cell immunity and related immune evasion in human cancers
Hu, X., Zhang, J., Wang, J., Fu, J., Li, T., Zheng, X., Wang, B., Gu, S., Jiang, P., Fan, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0339-x · Cited by 191
Li, J. J., Tsang, J. Y., & Tse, G. M. (2021) · Cancers · doi:10.3390/cancers13164233 · Cited by 180
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors
Mazor, R. D., Nathan, N., Gilboa, A., Stoler-Barak, L., Moss, L., Solomonov, I., Hanuna, A., Divinsky, Y., Shmueli, M. D., Hezroni, H., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.012 · Cited by 177
Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment
Lin, X., Xiao, Z., Chen, T., Liang, S. H., & Guo, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00317 · Cited by 173
Wang, W., Yuan, X.-L., Chen, H., Xie, G.-H., Ma, Y., Zheng, Y., Zhou, Y., & Shen, L.-S. (2015) · Oncotarget · doi:10.18632/oncotarget.5588 · Cited by 169
Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma
Ladányi, A. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12371 · Cited by 168
Wick, D. A., Webb, J. R., Nielsen, J. S., Martin, S. D., Kroeger, D. R., Milne, K., Castellarin, M. L., Twumasi‐Boateng, K., Watson, P. H., Holt, R. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2147 · Cited by 167
Self-citationB Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis
Yang, C., Lee, H., Pal, S., Jove, V., Deng, J., Zhang, W., Hoon, D. S. B., Wakabayashi, M., Forman, S., & Yu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064159 · Cited by 164
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
Stockmann, C., Schadendorf, D., Klose, R., & Helfrich, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00069 · Cited by 163
Autoantibodies: Opportunities for Early Cancer Detection
Macdonald, I. K., Parsy-Kowalska, C. B., & Chapman, C. J. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.02.003 · Cited by 162
Brown, J. R., Wimberly, H., Lannin, D. R., Nixon, C., Rimm, D. L., & Bossuyt, V. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1622 · Cited by 159
Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression
Li, Q., Lao, X., Pan, Q., Ning, N., Yet, J., Xu, Y., Li, S., & Chang, A. E. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0207 · Cited by 158
Yeong, J. P.-S., Lim, J. C. T., Lee, B. T. K., Li, H., Chia, N., Ong, C. C. H., Lye, W. K., Putti, T. C., Dent, R. A., Lim, E. H., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01209 · Cited by 157
Hladíková, K., Koucký, V., Bouček, J., Laco, J., Grega, M., Hodek, M., Zábrodský, M., Vošmik, M., Rozkošová, K., Vošmiková, H., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0726-6 · Cited by 155
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
Somasundaram, R., Zhang, G., Fukunaga-Kalabis, M., Perego, M., Krepler, C., Xu, X., Wagner, C., Hristova, D., Zhang, J., Tian, T., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00452-4 · Cited by 151
Yeong, J. P.-S., Thike, A. A., Lim, J. C. T., Lee, B. T. K., Li, H., Wong, S. C., Hue, S. S., Tan, P. H., & Iqbal, J. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4161-4 · Cited by 148
Characterization of tumor-associated B-cell subsets in patients with colorectal cancer
Shimabukuro‐Vornhagen, A., Schlößer, H., Gryschok, L., Malcher, J., Wennhold, K., Garcia-Marquez, M. A., Herbold, T., Neuhaus, L. S., Becker, H., Fiedler, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1701 · Cited by 147
Regulatory B cells in anti-tumor immunity
Zhang, Y., Gallastegui, N., & Rosenblatt, J. D. (2015) · International Immunology · doi:10.1093/intimm/dxv034 · Cited by 145
Song, I. H., Heo, S.-H., Bang, W. S., Park, H. S., Park, I. A., Kim, Y.-A., Park, S. Y., Roh, J., Gong, G., & Lee, H. J. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2016.215 · Cited by 143
Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients
Wei, X. L., Jin, Y., Tian, Y., Zhang, H., Wu, J., Lü, W., & Lu, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4538-0 · Cited by 138
An intact immune system is required for the anticancer activities of histone deacetylase inhibitors
West, A. C., Mattarollo, S. R., Shortt, J., Cluse, L. A., Christiansen, A. J., Smyth, M. J., & Johnstone, R. W. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0890 · Cited by 137
“A precise role for B cells in mediating tumor eradication has not been well documented, but there is evidence that effector B cells can be directly cytotoxic to tumor cells (39, 40), and produce IFN-γ and other stimulatory cytokines (41) as well as tumor-specific antibodies that would putatively enhance host anti-tumo…”
BackgroundFigenschau, S. L., Fismen, S., Fenton, K. A., Fenton, C. G., & Mortensen, E. (2015) · BMC Cancer · doi:10.1186/s12885-015-1116-1 · Cited by 136
Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
Liu, Y., Guo, J., & Huang, L. (2020) · Theranostics · doi:10.7150/thno.42998 · Cited by 134
The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead
Nelson, A., Lukacs, J., & Johnston, B. (2021) · Cancers · doi:10.3390/cancers13205174 · Cited by 133
Wirsing, A. M., Rikardsen, O., Steigen, S. E., Uhlin‐Hansen, L., & Hadler‐Olsen, E. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-38 · Cited by 128
Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome
Garg, K., Maurer‐Granofszky, M., Griss, J., Brüggen, M., Wolf, I. H., Wagner, C., Willi, N., Mertz, K. D., & Wagner, S. N. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.03.022 · Cited by 126
Angelis, C. D., Nagi, C. S., Hoyt, C. C., Liu, L., Roman, K., Wang, C., Zheng, Y., Veeraraghavan, J., Sethunath, V., Nuciforo, P. G., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1402 · Cited by 123
Wood, O., Woo, J., Seumois, G., Savelyeva, N., McCann, K. J., Singh, D. K., Jones, T. M., Peel, L., Breen, M. S., Ward, M. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10788 · Cited by 123
Milne, K., Alexander, C., Webb, J. R., Sun, W., Dillon, K. D., Kalloger, S. E., Gilks, C. B., Clarke, B. A., Köbel, M., & Nelson, B. H. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-33 · Cited by 122
Self-citationMyeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5
Wang, Y., Schafer, C. C., Hough, K. P., Tousif, S., Duncan, S. R., Kearney, J. F., Ponnazhagan, S., Hsu, H., & Deshane, J. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701069 · Cited by 122
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Zhu, Y., Yu, X., Thamphiwatana, S., Zheng, Y., & Pang, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.010 · Cited by 118
Feng, Q., Wei, H., Morihara, J. K., Stern, J., Yu, M., Kiviat, N. B., Hellström, I., & Hellström, K. E. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.07.098 · Cited by 117
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer
Hensler, M., Kašíková, L., Fišer, K., Raková, J., Škapa, P., Laco, J., Láníčková, T., Pecen, L., Truxová, I., Vosahlikova, S., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000979 · Cited by 116
The Role of Tumor-Infiltrating B Cells in Tumor Immunity
Guo, F. F., & Cui, J. W. (2019) · Journal of Oncology · doi:10.1155/2019/2592419 · Cited by 115
Coy, S., Rashid, R., Lin, J., Du, Z., Donson, A. M., Hankinson, T. C., Foreman, N. K., Manley, P. E., Kieran, M. W., Reardon, D. A., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy035 · Cited by 114
The Skin, a Novel Niche for Recirculating B Cells
Geherin, S. A., Fintushel, S. R., Lee, M. H., Wilson, R. P., Patel, R. T., Alt, C., Young, A. J., Hay, J. B., & Debes, G. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102639 · Cited by 110
Pimenta, E. M., & Barnes, B. J. (2014) · Cancers · doi:10.3390/cancers6020969 · Cited by 107
Why do human B cells secrete granzyme B? Insights into a novel B-cell differentiation pathway
Hagn, M., & Jahrsdörfer, B. (2012) · OncoImmunology · doi:10.4161/onci.22354 · Cited by 104
The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas
Annaratone, L., Cascardi, E., Vissio, E., Sarotto, I., Chmielik, E., Sapino, A., Berrino, E., & Marchiò, C. (2020) · Pathobiology · doi:10.1159/000507055 · Cited by 104
Autophagy: An adaptive metabolic response to stress shaping the antitumor immunity
Viry, E., Paggetti, J., Bagińska, J., Mgrditchian, T., Berchem, G., Moussay, E., & Janji, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.006 · Cited by 102
Wang, W., Zhong, Y., Zhuang, Z., Xie, J., Lu, Y., Huang, C., Sun, Y., Wu, L. L., Yin, J., Yu, H., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.253 · Cited by 100
Fang, L., Lowther, D. E., Meizlish, M. L., Anderson, R. C. E., Bruce, J. N., Devine, L., Huttner, A. J., Kleinstein, S. H., Lee, J. Y., Stern, J. N. H., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not110 · Cited by 100
Wirsing, A. M., Ervik, I. K., Seppola, M., Uhlin‐Hansen, L., Steigen, S. E., & Hadler‐Olsen, E. (2018) · Modern Pathology · doi:10.1038/s41379-018-0019-5 · Cited by 99
Tuminello, S., Veluswamy, R. R., Lieberman‐Cribbin, W., Gnjatic, S., Petralia, F., Wang, P., Flores, R. M., & Taioli, E. (2019) · Oncotarget · doi:10.18632/oncotarget.27392 · Cited by 98
Watermann, C., Pasternack, H., Idel, C., Ribbat‐Idel, J., Brägelmann, J., Kuppler, P., Offermann, A., Jonigk, D. D., Kühnel, M., Schröck, A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0197 · Cited by 95
Tumor-infiltrating B cells and T cells: Working together to promote patient survival
Nielsen, J. S., & Nelson, B. H. (2012) · OncoImmunology · doi:10.4161/onci.21650 · Cited by 95
Self-citationTargeting CD20 in Melanoma Patients at High Risk of Disease Recurrence
Pinc, A., Somasundaram, R., Wagner, C., Hörmann, M., Karanikas, G., Jalili, A., Bauer, W. M., Brunner, P. M., Grabmeier‐Pfistershammer, K., Gschaider, M., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.27 · Cited by 95
König, L., Mairinger, F. D., Hoffmann, O., Bittner, A., Schmid, K. W., Kimmig, R., Kasimir‐Bauer, S., & Bánkfalvi, Á. (2019) · BMC Cancer · doi:10.1186/s12885-019-5320-2 · Cited by 95
Arias‐Pulido, H., Cimino‐Mathews, A., Chaher, N., Qualls, C., Joste, N. E., Colpaert, C., Marotti, J. D., Foisey, M. G., Prossnitz, E. R., Emens, L. A., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4834-7 · Cited by 92
Chen, K., Ahmed, S. U., Adeyi, O. A., Dick, J. E., & Ghanekar, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039294 · Cited by 89
Mishra, A. K., Kadoishi, T., Wang, X., Driver, E., Chen, Z., Wang, J. H., & Wang, J. H. (2016) · Oncotarget · doi:10.18632/oncotarget.13228 · Cited by 88
Huang, X., Liu, Q., Zhong, G., Peng, Y., Liu, Y., Liang, L., Hong, H., Feng, W., Yang, S., Zhang, Y., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02510-2 · Cited by 87
Chen, Z., Tian, H., Yao, D.-M., Zhang, Y., Feng, Z., & Yang, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.738477 · Cited by 85
Loumagne, L., Baudhuin, J., Favier, B., Montespan, F., Carosella, E. D., & Rouas‐Freiss, N. (2014) · International Journal of Cancer · doi:10.1002/ijc.28845 · Cited by 83
Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
Castillo‐Rodríguez, R. A., Trejo‐Solís, C., Cabrera‐Cano, A., Gómez‐Manzo, S., & Dávila‐Borja, V. M. (2022) · Cancers · doi:10.3390/cancers14092291 · Cited by 80
Tumor-infiltrating B cells: The ignored players in tumor immunology
Linnebacher, M., & Maletzki, C. (2012) · OncoImmunology · doi:10.4161/onci.20641 · Cited by 79
Metadata
- Authors
- Nelson, B. H.
- Affiliations
- BC Cancer Agency (CA)
- Corresponding author
- Nelson, Brad H
- ORCID
- Nelson, Brad H
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-01
- Volume
- 185
- Issue
- 9
- Pages
- 4977-4982
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2107894271
- Semantic Scholar
- bf7939d1d9b47655a2abef372b8ceeacdc5af79b
- Cited by
- 416
- References
- 96
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 20 · 2023: 27 · 2022: 26 · 2021: 25 · 2020: 47 · 2019: 35 · 2018: 30 · 2017: 23 · 2016: 36 · 2015: 30 · 2014: 31 · 2013: 24 · 2012: 17
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD20+ B cells, tumor-infiltrating lymphocytes, tertiary lymphoid structures, tumor microenvironment, autoimmunity, organ transplantation, antigen presentation, chemokines, cytokines, tumor immunology
- MeSH terms
- Animals, B-Lymphocytes, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Autoimmunity, B-Lymphocyte Subsets, Lymphocytes, Tumor-Infiltrating, Antigens, CD20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.